GT Biopharma, Inc.

GTBP·NasdaqCM·Healthcare
Compare
4.8400−0.4300 (−8.16%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close5.2700
Open5.2800
Day range4.80005.2800
52-week range4.800028.7500
Off day high−8.33%
Off 52-week high−83.17%
Volume69.44K
Avg. volume (3M)65.34K
Market cap9.98M
EPS (TTM)-147.50
Forward P/E-0.45
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.83
Shares outstanding2.06M
Short interest13.53% of float
Earnings dateAug 12, 2025 (est.)
Analyst target75.0000
Profit margin0.00%

Against its peers

Compare in full ›
GTBP GRI INAB ATORX.ST IMM.L AIM
Market cap 9.98M 3.13M 9.18M 38.18M 21.88M 6.42M
P/E (TTM) — — — — — —
Forward P/E -0.4 -0.7 -1.0 -0.1 0.0 -0.4
Price/book 2.4 0.3 0.5 0.3 11.7 0.6
Dividend yield — — — — — —
1-year change −65.44% −97.10% −43.92% −99.44% −69.00% −90.12%
Today −8.16% −7.14% −2.02% 0.00% +7.50% +0.19%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All GTBP news ›

No recent coverage in the 4Search index.

From the 4Search news index, newest first.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance